Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Advanced Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India
- Status
- COMPLETED
- Phase
- PHASE4
Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bronchoscopic Cryo-Immunotherapy of Lung Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology
- Status
- COMPLETED
- Phase
- NA
Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation
- Status
- UNKNOWN
- Phase
- PHASE3
Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Early Stereotactic Body Radiation Therapy to the Primary Tumor in Advanced Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）
- Status
- COMPLETED
- Phase
- PHASE2
RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495)
- Status
- COMPLETED
- Phase
- PHASE2
AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Observational Cohort Study of Advanced Non-small Cell Lung Cancer (CAPTRA-LUNG)
- Status
- RECRUITING
- Phase
- N/A
Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC.
- Status
- COMPLETED
- Phase
- PHASE1
Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2